Physician
Haywood Pediatric and Adolescent Medicine Group, P.A.
Haywood Pediatric and Adolescent Medicine Group, P.A. was paid $11.72M by Medicaid between Jan 2018 and Dec 2024, across 63 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 35% of everything it billed.
33Billing provider infoHAYWOOD PEDIATRIC AND ADOLESCENT MEDICINE GROUP, P.A.
CLYDE, NC 28721
CLYDE, NC 28721
33aNPI1245231364assigned 08/10/2005
33bProvider typePediatric Adolescent Medicine Physician
28Total paid$11.72M
24GClaims585,014
24DCodes billed63
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatric Adolescent Medicine Physician providers in North Carolina
Rank by total paid#3 of 20
Median peer was paid$4.16M
This provider vs. median2.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 42,349 | $1.40M | |
| 2019 | 40,406 | $1.47M | |
| 2020 | 28,860 | $1.05M | |
| 2021 | 65,238 | $1.71M | |
| 2022 | 126,303 | $2.17M | |
| 2023 | 135,225 | $2.08M | |
| 2024incomplete | 146,633 | $1.84M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 35% | 66,156 | 58,348 | $4.11M |
| 99199 | Unlisted special service, procedure or report | 13% | 322,493 | 161,636 | $1.57M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 12% | 15,567 | 13,337 | $1.46M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 6.9% | 18,683 | 17,137 | $807K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.7% | 7,236 | 6,624 | $670K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.1% | 6,538 | 6,025 | $593K |
| 87428 | 3.9% | 7,553 | 6,555 | $460K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.9% | 4,454 | 4,065 | $452K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3.3% | 13,118 | 11,912 | $383K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.3% | 3,053 | 2,831 | $269K |
| 99051 | 1.7% | 8,100 | 7,350 | $204K | |
| 96127 | 1.2% | 26,044 | 22,777 | $144K |
51 more codes
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.0% | 12,328 | $123K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 3,897 | $78K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 5,552 | $75K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,931 | $68K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,604 | $60K |
| D0145 | Oral evaluation for a patient under three years of age | <1% | 986 | $29K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,476 | $20K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 106 | $15K |
| 87807 | <1% | 1,070 | $14K | |
| D1206 | Topical application of fluoride varnish | <1% | 1,003 | $13K |
| 90651 | <1% | 1,014 | $13K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 278 | $11K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 557 | $9K |
| 0001A | <1% | 112 | $7K | |
| 99401 | <1% | 187 | $7K | |
| 0002A | <1% | 103 | $7K | |
| 90686 | <1% | 8,618 | $6K | |
| 80061 | Lipid panel | <1% | 351 | $6K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 61 | $5K |
| 0071A | <1% | 113 | $5K | |
| 99070 | <1% | 598 | $5K | |
| 96161 | <1% | 1,228 | $5K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 81 | $4K |
| 0072A | <1% | 79 | $4K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 88 | $4K |
| 90734 | <1% | 439 | $3K | |
| 90621 | <1% | 228 | $2K | |
| 81025 | <1% | 234 | $2K | |
| 92551 | <1% | 17,905 | $2K | |
| 83655 | <1% | 95 | $1K | |
| 90619 | <1% | 427 | $1K | |
| 99177 | <1% | 9,186 | $764.47 | |
| 90656 | <1% | 779 | $303.74 | |
| 90715 | <1% | 120 | $263.40 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 16 | $134.12 |
| 81003 | <1% | 39 | $99.64 | |
| 90633 | <1% | 289 | $65.08 | |
| 99173 | <1% | 6,794 | $19.08 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 14 | $4.40 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 1,649 | $0.00 |
| 90680 | 0% | 440 | $0.00 | |
| 90677 | 0% | 316 | $0.00 | |
| 90698 | 0% | 1,156 | $0.00 | |
| 90744 | 0% | 75 | $0.00 | |
| 91307 | 0% | 236 | $0.00 | |
| 90696 | 0% | 12 | $0.00 | |
| 99000 | 0% | 50 | $0.00 | |
| 90670 | 0% | 1,519 | $0.00 | |
| 90685 | 0% | 272 | $0.00 | |
| 91300 | 0% | 258 | $0.00 | |
| 90710 | 0% | 50 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHENSON, CHRIS (BUSINESS MANAGER)